Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-01-31 09:04 am Sale | 13G | Charles River Laboratories International, Inc. CRL | FMR LLC | 557,203 1.095% | -2,212,925 (-79.89%) | View |
| 2023-01-24 1:56 pm Sale | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 4,981,145 9.8% | -98,881 (-1.95%) | View |
| 2022-02-09 3:33 pm Purchase | 13G | Charles River Laboratories International, Inc. CRL | VANGUARD GROUP INC | 5,869,125 11.63% | 841,221 (+16.73%) | View |
| 2022-02-09 09:11 am Purchase | 13G | Charles River Laboratories International, Inc. CRL | FMR LLC | 2,770,128 5.489% | 963,419 (+53.32%) | View |
| 2022-01-28 1:54 pm Sale | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 5,080,026 10.1% | -289,587 (-5.39%) | View |
| 2021-02-10 10:46 am Sale | 13G | Charles River Laboratories International, Inc. CRL | VANGUARD GROUP INC | 5,027,904 10.11% | -291,472 (-5.48%) | View |
| 2021-01-26 6:52 pm Purchase | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 5,369,613 10.8% | 28,230 (+0.53%) | View |
| 2020-07-10 10:39 am Purchase | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 5,341,383 10.8% | 847,430 (+18.86%) | View |
| 2020-02-11 7:19 pm Purchase | 13G | Charles River Laboratories International, Inc. CRL | VANGUARD GROUP INC | 5,319,376 10.89% | 36,537 (+0.69%) | View |
| 2020-02-05 11:25 am Sale | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 4,493,953 9.2% | -36,059 (-0.80%) | View |
| 2019-02-13 11:48 am Sale | 13G | Charles River Laboratories International, Inc. CRL | FMR LLC | 1,806,709 3.756% | -1,193,790 (-39.79%) | View |
| 2019-02-11 11:56 am Purchase | 13G | Charles River Laboratories International, Inc. CRL | VANGUARD GROUP INC | 5,282,839 10.98% | 226,969 (+4.49%) | View |
| 2019-02-04 10:09 am Purchase | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 4,530,012 9.4% | 495,694 (+12.29%) | View |
| 2018-02-13 09:35 am Purchase | 13G | Charles River Laboratories International, Inc. CRL | FMR LLC | 3,000,499 6.335% | 2,519,979 (+524.43%) | View |
| 2018-02-08 5:58 pm Purchase | 13G | Charles River Laboratories International, Inc. CRL | VANGUARD GROUP INC | 5,055,870 10.67% | 247,920 (+5.16%) | View |